| |
Article Title |
Author(s) |
Pages |
|
|
|
Contents
|
|
v-vi
|
|
| Review |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures
12 December 2011
Abstract: Background and aims: Patient-reported outcome measures (PROMs) make it possible to assess health-status problems from the perspective of persons suffering from a disease. The objective of th...
|
Ulrike Achleitner,
Michaela Coenen,
Jean-Frédéric Colombel,
Laurent Peyrin-Biroulet,
Narine Sahakyan,
Alarcos Cieza
et al.
|
507-517
|
|
| Regular Papers |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
14 November 2011
Abstract: Aim: Anti-tumor necrosis factor (TNF)-alpha agents are widely used for the treatment of both inflammatory bowel disease (IBD) and psoriasis. Psoriatic skin lesions induced by anti-TNF have b...
|
Iván Guerra,
Alicia Algaba,
José Lázaro Pérez-Calle,
María Chaparro,
Ignacio Marín-Jiménez,
Raquel García-Castellanos,
Yago González-Lama,
Antonio López-Sanromán,
Noemí Manceñido,
Pilar Martínez-Montiel,
Elvira Quintanilla,
Carlos Taxonera,
Mónica Villafruela,
Alberto Romero-Maté,
Pilar López-Serrano,
Javier P. Gisbert,
Fernando Bermejo
et al.
|
518-523
|
|
|
|
Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland
18 November 2011
Abstract: Background: An increased mortality has been reported in patients with Crohn's disease (CD), while figures have remained similar or decreased in patients with ulcerative colitis (UC) compared...
|
Pia Manninen,
Anna-Liisa Karvonen,
Heini Huhtala,
Martin Rasmussen,
Maarit Salo,
Leena Mustaniemi,
Ismo Pirttiniemi,
Pekka Collin
et al.
|
524-528
|
|
|
|
Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab
24 November 2011
Abstract: Background and aims: The effects of maintenance infliximab for Crohn's disease vary widely among patients. The aim of this study was to examine the cytokine profiles and to identify possible...
|
Kotaro Ogawa,
Takayuki Matsumoto,
Motohiro Esaki,
Takehiro Torisu,
Mitsuo Iida
et al.
|
529-535
|
|
|
|
Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis
05 December 2011
Abstract: Background and aim: Budesonide has been studied in patients with primary sclerosing cholangitis (PSC). This study was designed to evaluate the efficacy of oral budesonide on liver function t...
|
Udayakumar Navaneethan,
Preethi G.K. Venkatesh,
Ana E. Bennett,
Viral Patel,
Jeffrey Hammel,
Ravi P. Kiran,
Arthur J. McCullough,
Bo Shen
et al.
|
536-542
|
|
|
|
Clinical and radiographic presentation of superior mesenteric vein thrombosis in Crohn's disease: A single center experience
28 November 2011
Abstract: Background: Mesenteric vein thrombosis (MVT) is a rare and frequently underdiagnosed complicationof Crohn's disease (CD). This study describes the clinical and radiological characteristics o...
|
Uri Kopylov,
Marianne M. Amitai,
Aharon Lubetsky,
Rami Eliakim,
Yehuda Chowers,
Shomron Ben-Horin
et al.
|
543-549
|
|
|
|
Use of small bowel MRI enteroclysis in the management of paediatric IBD
02 December 2011
Abstract: Introduction: Children with inflammatory bowel disease (IBD) frequently present with small bowel involvement at some stage of their disease. Hence, reliable assessment of the entire small bo...
|
S. Sanka,
A. Gomez,
P. Set,
N. Rimareva,
R.J. Davies,
P. Rolfe,
G. Noble-Jamieson,
F. Torrente,
R. Heuschkel,
M. Zilbauer
et al.
|
550-556
|
|
|
|
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
12 December 2011
Abstract: Aim: To evaluate the effect of infliximab induction therapy on calprotectin levels in patients with ulcerative colitis (UC). Patients and Methods: In this prospective study 53 patients with ...
|
M. De Vos,
O. Dewit,
G. D'Haens,
F. Baert,
F. Fontaine,
S. Vermeire,
D. Franchimont,
T. Moreels,
D. Staessen,
L. Terriere,
B. Vander Cruyssen,
E. Louis,
on behalf of BIRD
et al.
|
557-562
|
|
|
|
Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels
14 December 2011
Abstract: Background and aim: The neuropeptide Substance P, plays a key role in modulating neuroimmune interactions in patients with inflammatory bowel diseases. We analyzed Substance P serum levels i...
|
Francesca Tavano,
F. Francesco di Mola,
Anna Latiano,
Orazio Palmieri,
Fabrizio Bossa,
Maria Rosa Valvano,
Tiziana Latiano,
Vito Annese,
Angelo Andriulli,
Pierluigi di Sebastiano
et al.
|
563-570
|
|
|
|
Personality and fatigue perception in a sample of IBD outpatients in remission: A preliminary study
05 December 2011
Abstract: Background and aims: Fatigue is considered as a feature of IBD. Nevertheless, medical variables would partly explain this complex phenomenon. Psychological variables would be especially conn...
|
Ingrid Banovic,
Daniel Gilibert,
Ahmed Jebrane,
Jacques Cosnes
|
571-577
|
|
|
|
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study
22 December 2011
Abstract: Background & Aims: The combined role of immunomodulators (IMM) and clinical characteristics of Inflammatory Bowel Disease (IBD) in determining the cancer risk is undefined. The aim was t...
|
Livia Biancone,
Sara Zuzzi,
Micaela Ranieri,
Carmelina Petruzziello,
Emma Calabrese,
Sara Onali,
Marta Ascolani,
Francesca Zorzi,
Giovanna Condino,
Simona Iacobelli,
Francesco Pallone
et al.
|
578-587
|
|
|
|
Thiopurine treatment in inflammatory bowel disease: Response predictors, safety, and withdrawal in follow-up
09 December 2011
Abstract: Background and aims: Thiopurines represent the mainstay of immunosuppressive therapy in inflammatory bowel diseases. Since it is likely that response to therapy and adverse events depends on...
|
Giuseppe Costantino,
Federica Furfaro,
Alessandra Belvedere,
Angela Alibrandi,
Walter Fries
et al.
|
588-596
|
|
|
|
A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease
19 December 2011
Abstract: Background: An imbalance between the production of reactive oxygen species (ROS) and their capturing by antioxidants results in oxidative stress, this may play an important role in the patho...
|
Hilbert S. de Vries,
Rene H.M. te Morsche,
Kevin Jenniskens,
Wilbert H.M. Peters,
Dirk J. de Jong
et al.
|
597-602
|
|
| Short Reports |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Internal fistula leakage due to a road traffic accident: A fortuitous diagnosis of Crohn's disease
12 December 2011
Abstract: Background and aim: Fistulae are one of the most frequent complications of Crohn's disease (CD) and occur in 30–40% of patients. Conversely, free perforation is a rare complication and is on...
|
Mathilde Wagner,
Jeremie H. Lefevre,
Benoit Royer,
Magali Svrcek,
Clément Pradel,
Emmanuel Tiret
et al.
|
603-605
|
|
|
|
Familial collagenous colitis involving a 6-year old child
26 December 2011
Abstract: Collagenous colitis is a recognised cause of persistent, non-bloody, watery diarrhoea. There are few cases of collagenous colitis reported in children or occurring within families. To our kn...
|
Perminder S. Phull,
Balasubramaniam Vijayan,
William M. Bisset,
Graeme I. Murray
|
606-609
|
|
|
|
Infliximab-induced psoriasis during therapy for Crohn's disease
27 January 2012
Abstract: Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-TNF-induced psoriasi...
|
Flavio Steinwurz,
Rafael Denadai,
Rogério Saad-Hossne,
Maria Luiza Queiroz,
Fábio Vieira Teixeira,
Ricardo Romiti
et al.
|
610-616
|
|
|
|
Surgical management of gluteal metastatic cutaneous Crohn's disease
27 January 2012
Abstract: Metastatic cutaneous Crohn's disease is a rare entity first described by McCallum et al. in 1976. It is diagnosed when histologically characteristic granulomata are seen at a site not contig...
|
Niamh Hogan,
Valerie Byrnes,
Alan Hussey,
Myles Joyce
|
617-620
|
|
| Viewpoint |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick?
19 March 2012
Inflammatory bowel diseases (IBDs), encompassing ulcerative colitis (UC) and Crohn's disease (CD) are chronic, progressive and relapsing pathologic conditions caused by a dysregulation of the immune s...
|
Renzo Caprilli,
Giovanni Latella,
Giuseppe Frieri
|
621-625
|
|
| Letters to the Editor |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Chronic hepatitis C, inflammatory bowel disease and interferon therapy
02 February 2012
|
Cumali Efe,
Emir Charles Roach,
Tugrul Purnak,
Ersan Ozaslan
|
626-627
|
|
|
|
Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp. paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins
13 February 2012
The association between Mycobacterium avium ssp. paratuberculosis (MAP) and Crohn's disease (CD) although debatable, is supported by several studies which have reported the detection or isolation of M...
|
Horacio Bach,
Greg Rosenfeld,
Brian Bressler
|
628-629
|
|
|
|
Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease
13 February 2012
We read with interest the report of infliximab-induced hepatitis by Doyle et al. Infliximab-induced liver test abnormalities are quite common in clinical practice; however, the progression to clinical...
|
Chiara van Casteren-Messidoro,
Gerrie Prins,
Antonie van Tilburg,
Zuzana Zelinkova,
Joeffrey Schouten,
Rob de Man
et al.
|
630-631
|
|
|
|
Anti chimeric antibodies against chimeric monoclonal antibodies may result in Kounis hypersensitivity associated acute coronary syndrome
16 February 2012
In the very important report published in this journal, a patient suffering from Crohn's disease with recurrent symptomatology and receiving repeated treatment with infliximab developed anaphylactic c...
|
Andreas Mazarakis,
Grigorios Tsigkas,
George D. Soufras,
Nicholas G. Kounis
|
632-633
|
|
|
|
Arthritis as a presenting symptom of subclinical Crohn's disease
14 March 2012
|
Bilal Ergül,
Erdem Koçak,
Seyfettin Köklü
|
634-635
|
|
|
|
Spot diagnosis: Eruptive melanocytic naevi during azathioprine therapy in Crohn's disease
09 March 2012
Long term use of thiopurines in the treatment of inflammatory bowel disease (IBD) is associated with the development of non-melanoma skin cancer. Here we present a patient who developed unusual skin a...
|
Janneke Wonders,
Nanne K.H. De Boer,
Stijn J.B. Van Weyenberg
|
636
|
|
|
|
Instructions for Authors
|
|
I-II
|
|
